Published in Lancet on August 13, 1977
Absence of central functional cholinergic deficits in myasthenia gravis. J Neurol Neurosurg Psychiatry (1989) 0.81
Association between myasthenia gravis and cognitive function: A systematic review and meta-analysis. Ann Indian Acad Neurol (2015) 0.75
Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science (1996) 6.02
Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature (1994) 5.70
Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med (1998) 3.72
Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature (1984) 3.71
Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science (1996) 3.35
Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol (1982) 3.24
IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur J Immunol (1998) 2.44
Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol (1987) 2.41
Production and detection of cold antihydrogen atoms. Nature (2002) 2.31
Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int (1982) 2.24
Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. EMBO J (1987) 2.23
On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur J Immunol (1989) 2.20
Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J Biol Chem (1995) 2.17
The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat Med (1995) 2.08
Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients. J Exp Med (1988) 2.02
Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc Natl Acad Sci U S A (1999) 1.99
A model of homelessness among male veterans of the Vietnam War generation. Am J Psychiatry (1994) 1.97
Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes (2001) 1.95
Old galaxies in the young Universe. Nature (2004) 1.90
Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J Immunol (1985) 1.88
Correlation between sites of limited proteolysis and segmental mobility in thermolysin. Biochemistry (1986) 1.80
Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. J Immunol (1989) 1.79
The acetylcholine receptor. I. Purification and characterization of a macromolecule isolated from Electrophorus electricus. J Biol Chem (1973) 1.75
Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction? J Immunol (1984) 1.71
Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1987) 1.68
Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol (1984) 1.68
Outcome of intensive inpatient treatment for combat-related posttraumatic stress disorder. Am J Psychiatry (1996) 1.65
Theta-frequency bursting and resonance in cerebellar granule cells: experimental evidence and modeling of a slow k+-dependent mechanism. J Neurosci (2001) 1.62
Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med (1997) 1.61
Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol (1989) 1.59
T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta. EMBO J (1987) 1.59
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial. Br J Cancer (2009) 1.54
Acetylcholine receptor and myasthenia gravis. Ann N Y Acad Sci (1976) 1.54
Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. J Neuroimmunol (1999) 1.53
Alcohol consumption and risk of Hodgkin's lymphoma and multiple myeloma: a multicentre case-control study. Ann Oncol (2006) 1.52
Dissociation and posttraumatic stress disorder in Vietnam combat veterans. Am J Psychiatry (1992) 1.52
The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain. Brain Res Brain Res Rev (1995) 1.51
Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res (1992) 1.51
Modification of the single tryptophan residue of staphylococcal nuclease by a new mild oxidizing agent. J Biol Chem (1970) 1.51
Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia. J Exp Med (1990) 1.48
TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain (2000) 1.47
Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia. J Immunol (1992) 1.47
Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest (1994) 1.45
Sulfenyl halides as modifying reagents for polypeptides and proteins. I. Modification of tryptophan residues. Biochemistry (1968) 1.41
Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression. J Exp Med (2001) 1.40
Chemokines and chemotaxis of leukocytes in infectious meningitis. J Neuroimmunol (1998) 1.40
Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J Exp Med (1988) 1.40
Chemicals and drugs as triggers of food-associated disorder. Ann Allergy (1988) 1.39
Images in cardiovascular medicine. Idiopathic hypereosinophilic vasculitis. Circulation (1995) 1.39
A galaxy rapidly forming stars 700 million years after the Big Bang at redshift 7.51. Nature (2013) 1.37
Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J Clin Invest (2001) 1.36
Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. J Cell Sci (1999) 1.35
Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J Clin Invest (1995) 1.35
Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett (1991) 1.35
Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur J Immunol (1998) 1.34
Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches. Eur J Immunol (2001) 1.33
Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. J Exp Med (2001) 1.32
Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. Nucleic Acids Res (1990) 1.32
Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1. Eur J Immunol (1997) 1.31
Involvement of the cystine transport system xc- in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J Immunol (1994) 1.30
Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur J Immunol (1999) 1.29
Acetylcholine receptor. Responses to drug binding. J Biol Chem (1977) 1.29
The structural basis for the regulation of tissue transglutaminase by calcium ions. Eur J Biochem (1999) 1.27
Haematopoietic cancer and medical history: a multicentre case control study. J Epidemiol Community Health (2000) 1.27
Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur J Immunol (1995) 1.26
Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women. Am J Ind Med (1999) 1.23
A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis. Clin Exp Immunol (1977) 1.23
Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol (1992) 1.23
Service system integration, access to services, and housing outcomes in a program for homeless persons with severe mental illness. Am J Public Health (1998) 1.22
Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis. Eur J Immunol (1998) 1.22
Experimental Listeria meningoencephalitis. Macrophage inflammatory protein-1 alpha and -2 are produced intrathecally and mediate chemotactic activity in cerebrospinal fluid of infected mice. J Immunol (1995) 1.22
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy. Pharmacogenomics J (2007) 1.20
Analysis of violent behavior in Vietnam combat veteran psychiatric inpatients with posttraumatic stress disorder. J Trauma Stress (1999) 1.18
TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL. Eur J Immunol (1998) 1.17
The role of denial in recovery from coronary heart disease. Psychosom Med (1987) 1.17
Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol (1990) 1.17
Astrocytes of the brain synthesize interleukin 3-like factors. J Immunol (1985) 1.15
Biosynthesis and metabolism of pterins in peripheral blood mononuclear cells and leukemia lines of man and mouse. Eur J Biochem (1987) 1.15
Puromycin-sensitive aminopeptidase. Sequence analysis, expression, and functional characterization. J Biol Chem (1995) 1.13
Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10. J Exp Med (1993) 1.12
Interconversion of methionine and methionine sulfoxide. Methods Enzymol (1977) 1.11
Astrocyte-derived interleukin 3 as a growth factor for microglia cells and peritoneal macrophages. J Immunol (1986) 1.09
Transforming growth factor-beta modulates T cell-mediated encephalitis caused by Borna disease virus. Pathogenic importance of CD8+ cells and suppression of antibody formation. J Immunol (1991) 1.09
Denervation of newborn rat muscle does not block the appearance of adult fast myosin heavy chain. Nature (1982) 1.08
Fas/APO-1 gene transfer for human malignant glioma. Cancer Res (1995) 1.08
Effect of clinician-veteran racial pairing in the treatment of posttraumatic stress disorder. Am J Psychiatry (1995) 1.07
Sulfenyl halides as modifying reagents for polypeptides and proteins. 3. Azobenzene-2-sulfenyl bromide, a selective reagent for cysteinyl residues. Biochemistry (1968) 1.07
Acute hepatitis complicating Mycoplasma pneumoniae infection. J Infect (1988) 1.07
Cleavage of the tryptophanyl peptide bond by dimethyl sulfoxide-hydrobromic acid. Methods Enzymol (1977) 1.06
Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivo. J Immunol (1992) 1.05
Delayed infection, family size and malignant lymphomas. J Epidemiol Community Health (2000) 1.05
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J Neuroimmunol (1998) 1.05
Mechanisms of brain injury in bacterial meningitis: workshop summary. Clin Infect Dis (1994) 1.04
A multicenter case-control study in Italy on hematolymphopoietic neoplasms and occupation. Epidemiology (2001) 1.04
IgA deficiency, epilepsy, and hydantoin medication. Lancet (1976) 1.03
Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann Neurol (1995) 1.03
Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone'. Prostaglandins Leukot Essent Fatty Acids (1995) 1.02